Lamivudine(LAM) Good Responder Study
- First Posted Date
- 2010-05-24
- Last Posted Date
- 2016-09-13
- Lead Sponsor
- ViiV Healthcare
- Target Recruit Count
- 1
- Registration Number
- NCT01128686
- Locations
- 🇰🇷
GSK Investigational Site, Kangwon-do, Korea, Republic of
A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-04-13
- Last Posted Date
- 2013-11-19
- Lead Sponsor
- ViiV Healthcare
- Target Recruit Count
- 297
- Registration Number
- NCT01102972
- Locations
- 🇵🇷
GSK Investigational Site, San Juan, Puerto Rico
A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-04-12
- Last Posted Date
- 2017-09-11
- Lead Sponsor
- ViiV Healthcare
- Target Recruit Count
- 15
- Registration Number
- NCT01101893
- Locations
- 🇺🇸
GSK Investigational Site, Buffalo, New York, United States
GSK1349572 Relative Bioavailability Study
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-04-02
- Last Posted Date
- 2017-06-09
- Lead Sponsor
- ViiV Healthcare
- Target Recruit Count
- 24
- Registration Number
- NCT01098513
- Locations
- 🇺🇸
GSK Investigational Site, Austin, Texas, United States
GSK1349572 Drug Interaction Study With Efavirenz
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-04-02
- Last Posted Date
- 2017-09-25
- Lead Sponsor
- ViiV Healthcare
- Target Recruit Count
- 12
- Registration Number
- NCT01098526
- Locations
- 🇺🇸
GSK Investigational Site, Buffalo, New York, United States
PENTA Fosamprenavir Study
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-03-01
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- ViiV Healthcare
- Target Recruit Count
- 1
- Registration Number
- NCT01077635
Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status
- First Posted Date
- 2010-03-01
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- ViiV Healthcare
- Target Recruit Count
- 1
- Registration Number
- NCT01077557
Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-02-15
- Last Posted Date
- 2019-06-24
- Lead Sponsor
- ViiV Healthcare
- Target Recruit Count
- 18
- Registration Number
- NCT01068925
- Locations
- 🇺🇸
GSK Investigational Site, Austin, Texas, United States
Effect Of Maraviroc On The Pharmacokinetics Of Digoxin
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2011-04-07
- Lead Sponsor
- ViiV Healthcare
- Target Recruit Count
- 12
- Registration Number
- NCT01056874
- Locations
- 🇸🇬
Pfizer Investigational Site, Singapore, Singapore
HIV Treatment and CVD Events
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-01-22
- Last Posted Date
- 2011-07-27
- Lead Sponsor
- ViiV Healthcare
- Registration Number
- NCT01054638
© Copyright 2024. All Rights Reserved by MedPath